CHRISTOPHER CONNOLLY: Open Payments
NPI 1881616167 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,065 in 113 payments from 26 companies in 2025. Trend: 2023 $1,808 · 2024 $1,893 · 2025 $2,065
Food & beverage: $2,065
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $289 |
| Amgen Inc. | 15 | $283 |
| Corcept Therapeutics | 6 | $192 |
| Novo Nordisk Inc | 12 | $180 |
| AstraZeneca Pharmaceuticals LP | 7 | $169 |
| PFIZER INC. | 9 | $140 |
| Lilly USA, LLC | 8 | $118 |
| Astellas Pharma US Inc | 3 | $84 |
| Abbott Laboratories | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $65 |
Products named: Korlym, EVENITY, VRAYLAR, Veozah, UBRELVY, Wegovy, QULIPTA, BREZTRI.
Industry payments across NE — which companies pay providers there.
